200 related articles for article (PubMed ID: 16021179)
1. PPARbeta/delta selectively induces differentiation and inhibits cell proliferation.
Kim DJ; Bility MT; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Cell Death Differ; 2006 Jan; 13(1):53-60. PubMed ID: 16021179
[TBL] [Abstract][Full Text] [Related]
2. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
[TBL] [Abstract][Full Text] [Related]
3. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
[TBL] [Abstract][Full Text] [Related]
4. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.
Bility MT; Devlin-Durante MK; Blazanin N; Glick AB; Ward JM; Kang BH; Kennett MJ; Gonzalez FJ; Peters JM
Carcinogenesis; 2008 Dec; 29(12):2406-14. PubMed ID: 18799709
[TBL] [Abstract][Full Text] [Related]
5. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
Burdick AD; Bility MT; Girroir EE; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2.
Zhu B; Bai R; Kennett MJ; Kang BH; Gonzalez FJ; Peters JM
Mol Cancer Ther; 2010 Dec; 9(12):3267-77. PubMed ID: 21159610
[TBL] [Abstract][Full Text] [Related]
7. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
Palkar PS; Borland MG; Naruhn S; Ferry CH; Lee C; Sk UH; Sharma AK; Amin S; Murray IA; Anderson CR; Perdew GH; Gonzalez FJ; Müller R; Peters JM
Mol Pharmacol; 2010 Sep; 78(3):419-30. PubMed ID: 20516370
[TBL] [Abstract][Full Text] [Related]
8. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.
Hollingshead HE; Borland MG; Billin AN; Willson TM; Gonzalez FJ; Peters JM
Carcinogenesis; 2008 Jan; 29(1):169-76. PubMed ID: 17893232
[TBL] [Abstract][Full Text] [Related]
9. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
[TBL] [Abstract][Full Text] [Related]
10. Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis.
Marin HE; Peraza MA; Billin AN; Willson TM; Ward JM; Kennett MJ; Gonzalez FJ; Peters JM
Cancer Res; 2006 Apr; 66(8):4394-401. PubMed ID: 16618765
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.
Girroir EE; Hollingshead HE; Billin AN; Willson TM; Robertson GP; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Toxicology; 2008 Jan; 243(1-2):236-43. PubMed ID: 18054822
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity.
Kim DJ; Murray IA; Burns AM; Gonzalez FJ; Perdew GH; Peters JM
J Biol Chem; 2005 Mar; 280(10):9519-27. PubMed ID: 15632134
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
Hollingshead HE; Killins RL; Borland MG; Girroir EE; Billin AN; Willson TM; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Carcinogenesis; 2007 Dec; 28(12):2641-9. PubMed ID: 17693664
[TBL] [Abstract][Full Text] [Related]
14. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.
Foreman JE; Sharma AK; Amin S; Gonzalez FJ; Peters JM
Cancer Lett; 2010 Feb; 288(2):219-25. PubMed ID: 19660859
[TBL] [Abstract][Full Text] [Related]
15. Regulation of epithelial-mesenchymal IL-1 signaling by PPARbeta/delta is essential for skin homeostasis and wound healing.
Chong HC; Tan MJ; Philippe V; Tan SH; Tan CK; Ku CW; Goh YY; Wahli W; Michalik L; Tan NS
J Cell Biol; 2009 Mar; 184(6):817-31. PubMed ID: 19307598
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin-like 4 regulates epidermal differentiation.
Pal M; Tan MJ; Huang RL; Goh YY; Wang XL; Tang MB; Tan NS
PLoS One; 2011; 6(9):e25377. PubMed ID: 21966511
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional repression of peroxisome proliferator-activated receptor beta/delta in murine keratinocytes by CCAAT/enhancer-binding proteins.
Di-Poï N; Desvergne B; Michalik L; Wahli W
J Biol Chem; 2005 Nov; 280(46):38700-10. PubMed ID: 16166081
[TBL] [Abstract][Full Text] [Related]
18. Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts.
Ali FY; Egan K; FitzGerald GA; Desvergne B; Wahli W; Bishop-Bailey D; Warner TD; Mitchell JA
Am J Respir Cell Mol Biol; 2006 Feb; 34(2):242-6. PubMed ID: 16239641
[TBL] [Abstract][Full Text] [Related]
19. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
Liang P; Jiang B; Yang X; Xiao X; Huang X; Long J; Zhang P; Zhang M; Xiao M; Xie T; Huang X
Exp Cell Res; 2008 Oct; 314(17):3142-51. PubMed ID: 18625220
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
Kim DJ; Prabhu KS; Gonzalez FJ; Peters JM
Carcinogenesis; 2006 May; 27(5):1105-12. PubMed ID: 16418176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
